CI:NYE-Cigna Corporation

EQUITY | Health Care Plans | New York Stock Exchange

Last Closing

USD 194.83

Change

0.00 (0.00)%

Market Cap

USD 35.85B

Volume

2.52M

Analyst Target

USD 247.21
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

Cigna Corp is a health services organization. The Company provides medical, dental, disability, life and accident insurance and related products and services.

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2019-01-20 )

Largest Industry Peers for Health Care Plans

ETFs Containing CI

PINK Simplify Exchange Traded .. 6.48 % 0.00 %

+0.27 (+1.09%)

USD 0.12B
FHI-B:CA CI Health Care Giants Cov.. 5.11 % 0.00 %

+0.16 (+1.09%)

CAD 0.05B
ZWHC:CA BMO Covered Call Health C.. 4.78 % 0.00 %

+0.20 (+1.09%)

CAD 0.01B
AILV 4.45 % 0.00 %

N/A

N/A
WBIL WBI BullBear Quality 3000.. 4.43 % 1.07 %

+0.10 (+1.09%)

USD 0.04B
STNC Stance Equity ESG Large C.. 3.75 % 0.00 %

+0.08 (+1.09%)

USD 0.11B
WHCS:SW iShares MSCI World Health.. 3.25 % 0.00 %

N/A

USD 1.07B
SPVU Invesco S&P 500® Enhance.. 2.75 % 0.16 %

+0.29 (+1.09%)

USD 0.11B
FSST Fidelity Sustainability U.. 2.42 % 0.00 %

+0.33 (+1.09%)

USD 0.01B
TDOC:CA TD Global Healthcare Lead.. 2.28 % 0.00 %

+0.13 (+1.09%)

CAD 0.07B
FHH:CA First Trust AlphaDEX US H.. 2.28 % 0.77 %

N/A

CAD 0.01B
FHH-F:CA First Trust AlphaDEX U.S... 2.28 % 0.00 %

N/A

CAD 0.01B
UPVLE:SW UBS (Irl) ETF plc - Facto.. 2.27 % 0.00 %

+0.01 (+1.09%)

USD 0.02B
UPVLD:SW UBS (Irl) ETF plc - Facto.. 2.27 % 0.00 %

+0.32 (+1.09%)

USD 0.35B
UPVLH:SW 2.27 % 0.00 %

N/A

N/A
XHS SPDR® S&P Health Care Se.. 2.11 % 0.35 %

+1.45 (+1.09%)

USD 0.08B
NSCR Nuveen Sustainable Core E.. 2.09 % 0.00 %

+0.27 (+1.09%)

USD 5.49M
RYH 1.70 % 0.40 %

N/A

N/A
RSPH Invesco S&P 500® Equal.. 1.65 % 0.00 %

+0.47 (+1.09%)

USD 1.02B
CSY9:XETRA Credit Suisse Index Fund .. 1.46 % 0.00 %

+1.20 (+1.09%)

USD 0.29B
IQSA:LSE Invesco Quantitative Stra.. 1.45 % 0.00 %

+1.24 (+1.09%)

USD 0.24B
WELE:XETRA Amundi S&P 500 Equal Weig.. 0.66 % 0.00 %

+0.12 (+1.09%)

USD 1.17B
VVL:CA Vanguard Global Value Fac.. 0.64 % 0.40 %

+0.39 (+1.09%)

CAD 0.35B
XZEW:XETRA Xtrackers S&P 500 Equal W.. 0.42 % 0.00 %

+0.33 (+1.09%)

USD 0.56B
ESGL ESGL Holdings Limited Ord.. 0.00 % 0.40 %

-0.01 (1.09%)

USD 5.46M
FUM:CA 0.00 % 0.80 %

N/A

N/A
FXH First Trust Health Care A.. 0.00 % 0.63 %

+1.77 (+1.09%)

USD 1.33B
IHF iShares U.S. Healthcare P.. 0.00 % 0.43 %

+0.26 (+1.09%)

USD 0.82B
QSY 0.00 % 0.38 %

N/A

N/A
HONR 0.00 % 0.65 %

N/A

N/A
FHI:CA CI Health Care Giants Cov.. 0.00 % 0.75 %

+0.16 (+1.09%)

CAD 0.08B
BUYB:LSE Invesco Global Buyback Ac.. 0.00 % 0.00 %

+0.76 (+1.09%)

USD 0.05B
XXM:CA 0.00 % 0.68 %

N/A

N/A
UC96:LSE UBS (Irl) ETF plc - Facto.. 0.00 % 0.00 %

+11.00 (+1.09%)

USD 0.35B
UPVL:LSE UBS (Irl) ETF plc - Facto.. 0.00 % 0.00 %

+19.25 (+1.09%)

USD 8.21M
XMWD:LSE Xtrackers MSCI World Swap.. 0.00 % 0.00 %

+1.71 (+1.09%)

USD 4.20B
BUYB:PA Invesco Global Buyback Ac.. 0.00 % 0.00 %

+0.45 (+1.09%)

USD 0.05B
TPHC:PA Amundi Index Solutions - .. 0.00 % 0.00 %

+0.73 (+1.09%)

USD 7.32M
TPXE:PA Amundi Index Solutions - .. 0.00 % 0.00 %

+0.01 (+1.09%)

USD 0.35B
TPXH:PA Amundi Index Solutions - .. 0.00 % 0.00 %

+2.57 (+1.09%)

USD 0.27B
BBCK:F Invesco Markets III plc -.. 0.00 % 0.00 %

+0.47 (+1.09%)

USD 0.05B
UBUS:F UBS (Irl) ETF Public Limi.. 0.00 % 0.00 %

+0.01 (+1.09%)

USD 0.33B
UBUW:F UBS (Irl) ETF Public Limi.. 0.00 % 0.00 %

+0.17 (+1.09%)

USD 0.02B
BBCK:XETRA Invesco Global Buyback Ac.. 0.00 % 0.00 %

+0.39 (+1.09%)

USD 0.05B
TTPX:XETRA Amundi Index Solutions - .. 0.00 % 0.00 %

+2.65 (+1.09%)

USD 0.40B
UBUS:XETRA UBS (Irl) ETF plc - Facto.. 0.00 % 0.00 %

+0.22 (+1.09%)

USD 0.49B
UBUW:XETRA UBS (Irl) ETF plc - Facto.. 0.00 % 0.00 %

+0.35 (+1.09%)

USD 0.05B
VGVL:XETRA 0.00 % 0.00 %

N/A

N/A
VMUS:XETRA 0.00 % 0.00 %

N/A

N/A
HDIV 0.00 % 0.00 %

N/A

N/A
CBUF:XETRA iShares MSCI World Health.. 0.00 % 0.00 %

+0.06 (+1.09%)

USD 1.13B
NTZG Nuveen Global Net Zero Tr.. 0.00 % 0.00 %

+0.23 (+1.09%)

USD 6.17M
AGED:SW iShares Ageing Population.. 0.00 % 0.00 %

+0.15 (+1.09%)

N/A
BUYB:SW Invesco Global Buyback Ac.. 0.00 % 0.00 %

N/A

N/A

Market Performance

  Market Performance vs. Industry/Classification (Health Care Plans) Market Performance vs. Exchange (New York Stock Exchange)
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 2.59% 29% F 24% F
Dividend Return N/A N/A N/A N/A F
Total Return 2.59% 29% F 24% F
Trailing 12 Months  
Capital Gain -11.50% 25% F 42% F
Dividend Return 0.02% 20% F N/A F
Total Return -11.48% 25% F 34% F
Trailing 5 Years  
Capital Gain 117.78% 25% F 95% A
Dividend Return 0.22% 20% F 2% F
Total Return 118.01% 25% F 94% A
Average Annual (5 Year Horizon)  
Capital Gain 22.51% 25% F 93% A
Dividend Return 22.54% 25% F 92% A
Total Return 0.03% 20% F 2% F
Risk Return Profile  
Volatility (Standard Deviation) 24.26% 63% D 26% F
Risk Adjusted Return 92.91% 38% F 82% B
Market Capitalization 35.85B 75% C 98% N/A

Key Financial Ratios

  Ratio vs. Industry/Classification (Health Care Plans) Ratio vs. Market (New York Stock Exchange)
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
Market Value  
Price / Earning Ratio 18.60 88% 38%
Price/Book Ratio 3.22 63% 22%
Price / Cash Flow Ratio 2.85 50% 43%
Price/Free Cash Flow Ratio 12.67 63% 46%
Management Effectiveness  
Return on Equity 18.95% 88% 79%
Return on Invested Capital N/A N/A N/A
Return on Assets 4.07% 50% 61%
Debt to Equity Ratio 68.50% 50% 52%

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior return on equity

The company management has delivered better return on equity in the most recent 4 quarters than its peers, placing it in the top quartile.

Underpriced compared to earnings

The stock is trading low compared to its peers on a price to earning basis and is in the top quartile. It may be underpriced but do check its financial performance to make sure there is no specific reason.

High market capitalization

This is one of the largest entities in its sector and is among the top quartile. Such companies tend to be more stable.

Positive cash flow

The company had positive total cash flow in the most recent four quarters.

Positive free cash flow

The company had positive total free cash flow in the most recent four quarters.

What to not like:
Poor risk adjusted returns

This company is delivering below median risk adjusted returns in its peers. Even if it is outperforming on returns , the returns are unpredictable. Proceed with caution.

Highly leveraged

The company is in the bottom half compared to its sector peers on debt to equity and is highly leveraged. However, do check the news and look at its sector and management statements. Sometimes this is high because the company is trying to grow aggressively.

Poor return on assets

The company management has delivered below median return on assets in the most recent 4 quarters compared to its peers.

Overpriced on cashflow basis

The stock is trading high compared to its peers on a price to cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.

Below median dividend returns

The company’s average income yield over the past 5 years has been low compared to its peers. However, it is not a problem if you are not looking for income.

Below median total returns

The company has under performed its peers on annual average total returns in the past 5 years.

Low Earnings Growth

This stock has shown below median earnings growth in the previous 5 years compared to its sector

Low Revenue Growth

This stock has shown below median revenue growth in the previous 5 years compared to its sector